Orexo AB will acquire PharmaKodex Ltd., a UK-based drug delivery company with several ready-to-partner preclinical and early clinical projects focused on improving oral, sublingual and transdermal medication. Orexo will acquire the company for a consideration to be paid in new Orexo shares and a second payment of either new Orexo shares or cash at Orexo’s option. Additional Orexo shares as the first payment may be issued in August 2009 unless Orexo opts for the second payment in cash. The tra...